Human Gene Patents 'Surprisingly High,' A New Study Shows
By Wall Street Journal,
Wall Street Journal
| 10. 14. 2005
At least 18.5% of human genes are covered by U.S. patents, say researchers who have produced the first comprehensive map of the patent landscape for the genome.
The researchers called the figure "surprisingly high" and their findings, published in Friday's issue of the journal Science, are likely to add fuel to an already heated debate over ownership and the right to exploit human gene sequences commercially.
U.S. and European patent law preclude anyone from patenting a gene as it exists in the human body. But for several decades, inventors and institutions have been filing for patents by claiming a proprietary way of isolating the genes or developing a specific therapeutic use for them that is claimed to be unique.
They have also been making similar claims over the specific proteins that each gene instructs cells to produce. A well-known example is erythropoietin, a blood protein manufactured as the blockbuster drug Epogen to stimulate the production of red blood cells and whose patent rights are owned by Amgen Corp.
But gene patents can still be subject to dispute. BRCA1, a gene...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...